Skip to main content
NCBI home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1996 Sep;60(3):473–482. doi: 10.1128/mr.60.3.473-482.1996

Virus-encoded superantigens.

B T Huber 1, P N Hsu 1, N Sutkowski 1
PMCID: PMC239452  PMID: 8840782

Abstract

Superantigens are microbial agents that have a strong effect on the immune response of the host. Their initial target is the T lymphocyte, but a whole cascade of immunological reactions ensues. It is thought that the microbe engages the immune system of the host to its own advantage, to facilitate persistent infection and/or transmission. In this review, we discuss in detail the structure and function of the superantigen encoded by the murine mammary tumor virus, a B-type retrovirus which is the causative agent of mammary carcinoma. We will also outline what has more recently become known about superantigen activity associated with two human herpesviruses, cytomegalovirus and Epstein-Barr virus. It is likely that we have only uncovered the tip of the iceberg in our discovery of microbial superantigens, and we predict a flood of new information on this topic shortly.

Full Text

The Full Text of this article is available as a PDF (420.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., Held W., Waanders G. A., Shakhov A. N., Scarpellino L., Lees R. K., MacDonald H. R. Exogenous and endogenous mouse mammary tumor virus superantigens. Immunol Rev. 1993 Feb;131:5–25. doi: 10.1111/j.1600-065x.1993.tb01527.x. [DOI] [PubMed] [Google Scholar]
  2. Acha-Orbea H., Shakhov A. N., Scarpellino L., Kolb E., Müller V., Vessaz-Shaw A., Fuchs R., Blöchlinger K., Rollini P., Billotte J. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature. 1991 Mar 21;350(6315):207–211. doi: 10.1038/350207a0. [DOI] [PubMed] [Google Scholar]
  3. Ambroziak J. A., Blackbourn D. J., Herndier B. G., Glogau R. G., Gullett J. H., McDonald A. R., Lennette E. T., Levy J. A. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 1995 Apr 28;268(5210):582–583. doi: 10.1126/science.7725108. [DOI] [PubMed] [Google Scholar]
  4. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Séguin C. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984 Jul 19;310(5974):207–211. doi: 10.1038/310207a0. [DOI] [PubMed] [Google Scholar]
  5. Beutner U., Frankel W. N., Cote M. S., Coffin J. M., Huber B. T. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5432–5436. doi: 10.1073/pnas.89.12.5432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beutner U., Kraus E., Kitamura D., Rajewsky K., Huber B. T. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med. 1994 May 1;179(5):1457–1466. doi: 10.1084/jem.179.5.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beutner U., McLellan B., Kraus E., Huber B. T. Lack of MMTV superantigen presentation in MHC class II-deficient mice. Cell Immunol. 1996 Mar 15;168(2):141–147. doi: 10.1006/cimm.1996.0060. [DOI] [PubMed] [Google Scholar]
  8. Bijlmakers M. J., Benaroch P., Ploegh H. L. Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J. 1994 Jun 1;13(11):2699–2707. doi: 10.1002/j.1460-2075.1994.tb06560.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bill J., Palmer E. Positive selection of CD4+ T cells mediated by MHC class II-bearing stromal cell in the thymic cortex. Nature. 1989 Oct 19;341(6243):649–651. doi: 10.1038/341649a0. [DOI] [PubMed] [Google Scholar]
  10. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995 May 4;332(18):1186–1191. doi: 10.1056/NEJM199505043321802. [DOI] [PubMed] [Google Scholar]
  11. Choi Y., Kappler J. W., Marrack P. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature. 1991 Mar 21;350(6315):203–207. doi: 10.1038/350203a0. [DOI] [PubMed] [Google Scholar]
  12. Choi Y., Marrack P., Kappler J. W. Structural analysis of a mouse mammary tumor virus superantigen. J Exp Med. 1992 Mar 1;175(3):847–852. doi: 10.1084/jem.175.3.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cohen J. C., Varmus H. E. Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature. 1979 Mar 29;278(5703):418–423. doi: 10.1038/278418a0. [DOI] [PubMed] [Google Scholar]
  14. Dellabona P., Peccoud J., Kappler J., Marrack P., Benoist C., Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell. 1990 Sep 21;62(6):1115–1121. doi: 10.1016/0092-8674(90)90388-u. [DOI] [PubMed] [Google Scholar]
  15. Denzin L. K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 1995 Jul 14;82(1):155–165. doi: 10.1016/0092-8674(95)90061-6. [DOI] [PubMed] [Google Scholar]
  16. Dobrescu D., Kabak S., Mehta K., Suh C. H., Asch A., Cameron P. U., Hodtsev A. S., Posnett D. N. Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain V beta subsets. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5563–5567. doi: 10.1073/pnas.92.12.5563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Donehower L. A., Fleurdelys B., Hager G. L. Further evidence for the protein coding potential of the mouse mammary tumor virus long terminal repeat: nucleotide sequence of an endogenous proviral long terminal repeat. J Virol. 1983 Mar;45(3):941–949. doi: 10.1128/jvi.45.3.941-949.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Donehower L. A., Huang A. L., Hager G. L. Regulatory and coding potential of the mouse mammary tumor virus long terminal redundancy. J Virol. 1981 Jan;37(1):226–238. doi: 10.1128/jvi.37.1.226-238.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Driscoll J., Brown M. G., Finley D., Monaco J. J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature. 1993 Sep 16;365(6443):262–264. doi: 10.1038/365262a0. [DOI] [PubMed] [Google Scholar]
  20. Dyson P. J., Knight A. M., Fairchild S., Simpson E., Tomonari K. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature. 1991 Feb 7;349(6309):531–532. doi: 10.1038/349531a0. [DOI] [PubMed] [Google Scholar]
  21. Festenstein H. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant Rev. 1973;15:62–88. doi: 10.1111/j.1600-065x.1973.tb00111.x. [DOI] [PubMed] [Google Scholar]
  22. Fleischer B., Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med. 1988 May 1;167(5):1697–1707. doi: 10.1084/jem.167.5.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fleischer B. Stimulation of human T cells by microbial 'superantigens'. Immunol Res. 1991;10(3-4):349–355. doi: 10.1007/BF02919720. [DOI] [PubMed] [Google Scholar]
  24. Frankel W. N., Rudy C., Coffin J. M., Huber B. T. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature. 1991 Feb 7;349(6309):526–528. doi: 10.1038/349526a0. [DOI] [PubMed] [Google Scholar]
  25. Gaugler B., Langlet C., Martin J. M., Schmitt-Verhulst A. M., Guimezanes A. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies. Eur J Immunol. 1991 Oct;21(10):2581–2589. doi: 10.1002/eji.1830211040. [DOI] [PubMed] [Google Scholar]
  26. Ghosh P., Amaya M., Mellins E., Wiley D. C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 1995 Nov 30;378(6556):457–462. doi: 10.1038/378457a0. [DOI] [PubMed] [Google Scholar]
  27. Golovkina T. V., Chervonsky A., Dudley J. P., Ross S. R. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell. 1992 May 15;69(4):637–645. doi: 10.1016/0092-8674(92)90227-4. [DOI] [PubMed] [Google Scholar]
  28. Hammer J., Bono E., Gallazzi F., Belunis C., Nagy Z., Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med. 1994 Dec 1;180(6):2353–2358. doi: 10.1084/jem.180.6.2353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hara T., Jung L. K., Bjorndahl J. M., Fu S. M. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med. 1986 Dec 1;164(6):1988–2005. doi: 10.1084/jem.164.6.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Held W., Shakhov A. N., Izui S., Waanders G. A., Scarpellino L., MacDonald H. R., Acha-Orbea H. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med. 1993 Feb 1;177(2):359–366. doi: 10.1084/jem.177.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Held W., Waanders G. A., Shakhov A. N., Scarpellino L., Acha-Orbea H., MacDonald H. R. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell. 1993 Aug 13;74(3):529–540. doi: 10.1016/0092-8674(93)80054-i. [DOI] [PubMed] [Google Scholar]
  32. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Herman A., Croteau G., Sekaly R. P., Kappler J., Marrack P. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med. 1990 Sep 1;172(3):709–717. doi: 10.1084/jem.172.3.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hsu P. N., Huber B. T. Superantigens. Gazing into the crystal ball. Curr Biol. 1995 Mar 1;5(3):235–237. doi: 10.1016/s0960-9822(95)00047-9. [DOI] [PubMed] [Google Scholar]
  35. Janeway C. A., Jr, Katz M. E. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens. J Immunol. 1985 Apr;134(4):2057–2063. [PubMed] [Google Scholar]
  36. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
  37. Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987 Apr 24;49(2):273–280. doi: 10.1016/0092-8674(87)90568-x. [DOI] [PubMed] [Google Scholar]
  38. Kappler J. W., Staerz U., White J., Marrack P. C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature. 1988 Mar 3;332(6159):35–40. doi: 10.1038/332035a0. [DOI] [PubMed] [Google Scholar]
  39. Kim J., Urban R. G., Strominger J. L., Wiley D. C. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science. 1994 Dec 16;266(5192):1870–1874. doi: 10.1126/science.7997880. [DOI] [PubMed] [Google Scholar]
  40. Knight A. M., Harrison G. B., Pease R. J., Robinson P. J., Dyson P. J. Biochemical analysis of the mouse mammary tumor virus long terminal repeat product. Evidence for the molecular structure of an endogenous superantigen. Eur J Immunol. 1992 Mar;22(3):879–882. doi: 10.1002/eji.1830220339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Korman A. J., Bourgarel P., Meo T., Rieckhof G. E. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 1992 May;11(5):1901–1905. doi: 10.1002/j.1460-2075.1992.tb05242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Lafon M., Lafage M., Martinez-Arends A., Ramirez R., Vuillier F., Charron D., Lotteau V., Scott-Algara D. Evidence for a viral superantigen in humans. Nature. 1992 Aug 6;358(6386):507–510. doi: 10.1038/358507a0. [DOI] [PubMed] [Google Scholar]
  43. Lafon M., Scott-Algara D., Marche P. N., Cazenave P. A., Jouvin-Marche E. Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen. J Exp Med. 1994 Oct 1;180(4):1207–1215. doi: 10.1084/jem.180.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Liu H., Lampe M. A., Iregui M. V., Cantor H. Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8705–8709. doi: 10.1073/pnas.88.19.8705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lynch D. H., Gress R. E., Needleman B. W., Rosenberg S. A., Hodes R. J. T cell responses to Mls determinants are restricted by cross-reactive MHC determinants. J Immunol. 1985 Apr;134(4):2071–2078. [PubMed] [Google Scholar]
  46. MURRAY W. S. MA/My strain of the Marsh albino mouse. J Natl Cancer Inst. 1963 Mar;30:605–610. [PubMed] [Google Scholar]
  47. MacDonald H. R., Lees R. K., Schneider R., Zinkernagel R. M., Hengartner H. Positive selection of CD4+ thymocytes controlled by MHC class II gene products. Nature. 1988 Dec 1;336(6198):471–473. doi: 10.1038/336471a0. [DOI] [PubMed] [Google Scholar]
  48. MacDonald H. R., Schneider R., Lees R. K., Howe R. C., Acha-Orbea H., Festenstein H., Zinkernagel R. M., Hengartner H. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 1988 Mar 3;332(6159):40–45. doi: 10.1038/332040a0. [DOI] [PubMed] [Google Scholar]
  49. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  50. Marrack P., Kushnir E., Kappler J. A maternally inherited superantigen encoded by a mammary tumour virus. Nature. 1991 Feb 7;349(6309):524–526. doi: 10.1038/349524a0. [DOI] [PubMed] [Google Scholar]
  51. Miyashita E. M., Yang B., Lam K. M., Crawford D. H., Thorley-Lawson D. A. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 1995 Feb 24;80(4):593–601. doi: 10.1016/0092-8674(95)90513-8. [DOI] [PubMed] [Google Scholar]
  52. Moore P. S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995 May 4;332(18):1181–1185. doi: 10.1056/NEJM199505043321801. [DOI] [PubMed] [Google Scholar]
  53. Moss D. J., Rickinson A. B., Pope J. H. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer. 1978 Dec;22(6):662–668. doi: 10.1002/ijc.2910220604. [DOI] [PubMed] [Google Scholar]
  54. Mottershead D. G., Hsu P. N., Urban R. G., Strominger J. L., Huber B. T. Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity. 1995 Feb;2(2):149–154. doi: 10.1016/s1074-7613(95)80027-1. [DOI] [PubMed] [Google Scholar]
  55. Nilsson K., Klein G., Henle W., Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer. 1971 Nov 15;8(3):443–450. doi: 10.1002/ijc.2910080312. [DOI] [PubMed] [Google Scholar]
  56. O'Rourke A. M., Mescher M. F., Webb S. R. Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants. Science. 1990 Jul 13;249(4965):171–174. doi: 10.1126/science.2164711. [DOI] [PubMed] [Google Scholar]
  57. Park C. G., Jung M. Y., Choi Y., Winslow G. M. Proteolytic processing is required for viral superantigen activity. J Exp Med. 1995 May 1;181(5):1899–1904. doi: 10.1084/jem.181.5.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Patarca R., Wei F. Y., Iregui M. V., Cantor H. Differential induction of interferon gamma gene expression after activation of CD4+ T cells by conventional antigen and Mls superantigen. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2736–2739. doi: 10.1073/pnas.88.7.2736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Payne J., Huber B. T. Minor lymphocyte stimulatory antigen-bearing stimulator cells require lipopolysaccharide activation to induce programmed cell death in T cell hybridomas. J Immunol. 1992 Sep 1;149(5):1571–1576. [PubMed] [Google Scholar]
  60. Pullen A. M., Choi Y., Kushnir E., Kappler J., Marrack P. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. J Exp Med. 1992 Jan 1;175(1):41–47. doi: 10.1084/jem.175.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Reinherz E. L., O'Brien C., Rosenthal P., Schlossman S. F. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol. 1980 Sep;125(3):1269–1274. [PubMed] [Google Scholar]
  62. Rellahan B. L., Jones L. A., Kruisbeek A. M., Fry A. M., Matis L. A. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med. 1990 Oct 1;172(4):1091–1100. doi: 10.1084/jem.172.4.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Rochford R., Mosier D. E. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol. 1995 Jan;69(1):150–155. doi: 10.1128/jvi.69.1.150-155.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Rudy C. K., Kraus E., Palmer E., Huber B. T. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7. J Exp Med. 1992 Jun 1;175(6):1613–1621. doi: 10.1084/jem.175.6.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Saito I., Servenius B., Compton T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med. 1989 Jun 1;169(6):2191–2198. doi: 10.1084/jem.169.6.2191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Salmons B., Günzburg W. H. Current perspectives in the biology of mouse mammary tumour virus. Virus Res. 1987 Aug;8(2):81–102. doi: 10.1016/0168-1702(87)90022-0. [DOI] [PubMed] [Google Scholar]
  67. Sloan V. S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D. M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature. 1995 Jun 29;375(6534):802–806. doi: 10.1038/375802a0. [DOI] [PubMed] [Google Scholar]
  68. Subramanyam M., McLellan B., Labrecque N., Sekaly R. P., Huber B. T. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J Immunol. 1993 Sep 1;151(5):2538–2545. [PubMed] [Google Scholar]
  69. Suh W. K., Cohen-Doyle M. F., Fruh K., Wang K., Peterson P. A., Williams D. B. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science. 1994 May 27;264(5163):1322–1326. doi: 10.1126/science.8191286. [DOI] [PubMed] [Google Scholar]
  70. Sumida T., Sakamaki T., Yonaha F., Maeda T., Namekawa T., Nawata Y., Takabayashi K., Iwamoto I., Yoshida S. HLA-DR alleles in patients with Sjögren's syndrome over-representing V beta 2 and V beta 13 genes in the labial salivary glands. Br J Rheumatol. 1994 May;33(5):420–424. doi: 10.1093/rheumatology/33.5.420. [DOI] [PubMed] [Google Scholar]
  71. Sumida T., Yonaha F., Maeda T., Tanabe E., Koike T., Tomioka H., Yoshida S. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest. 1992 Feb;89(2):681–685. doi: 10.1172/JCI115635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Sutkowski N., Thorley-Lawson D. A., Huber B. T. The interplay of herpesviruses in AIDS: superantigen sharing. Trends Microbiol. 1996 Mar;4(3):89–91. doi: 10.1016/0966-842X(96)81521-6. [DOI] [PubMed] [Google Scholar]
  73. Thorley-Lawson D. A., Chess L., Strominger J. L. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J Exp Med. 1977 Aug 1;146(2):495–508. doi: 10.1084/jem.146.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Tomkinson B. E., Maziarz R., Sullivan J. L. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J Immunol. 1989 Jul 15;143(2):660–670. [PubMed] [Google Scholar]
  75. Tomkinson B. E., Wagner D. K., Nelson D. L., Sullivan J. L. Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol. 1987 Dec 1;139(11):3802–3807. [PubMed] [Google Scholar]
  76. Tsiagbe V. K., Asakawa J., Miranda A., Sutherland R. M., Paterson Y., Thorbecke G. J. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells. J Immunol. 1993 Jun 15;150(12):5519–5528. [PubMed] [Google Scholar]
  77. Tsiagbe V. K., Yoshimoto T., Asakawa J., Cho S. Y., Meruelo D., Thorbecke G. J. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 1993 Jun;12(6):2313–2320. doi: 10.1002/j.1460-2075.1993.tb05885.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Van Bockstaele D. R., Lenjou M., Snoeck H. W., Lardon F., Peetermans M. E. Effect of retinoic acid (RA) on myeloid progenitors in normal bone marrow (BM) Leukemia. 1994 Jan;8(1):214–215. [PubMed] [Google Scholar]
  79. Veronese M. L., Veronesi A., D'Andrea E., Del Mistro A., Indraccolo S., Mazza M. R., Mion M., Zamarchi R., Menin C., Panozzo M. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med. 1992 Dec 1;176(6):1763–1767. doi: 10.1084/jem.176.6.1763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Veronesi A., Coppola V., Veronese M. L., Menin C., Bruni L., D'Andrea E., Mion M., Amadori A., Chieco-Bianchi L. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell- injected scid mice. II. Role of host and donor factors in tumor generation. Int J Cancer. 1994 Dec 1;59(5):676–683. doi: 10.1002/ijc.2910590516. [DOI] [PubMed] [Google Scholar]
  81. White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989 Jan 13;56(1):27–35. doi: 10.1016/0092-8674(89)90980-x. [DOI] [PubMed] [Google Scholar]
  82. Winslow G. M., Scherer M. T., Kappler J. W., Marrack P. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a). Cell. 1992 Nov 27;71(5):719–730. doi: 10.1016/0092-8674(92)90549-r. [DOI] [PubMed] [Google Scholar]
  83. Woodland D. L., Happ M. P., Gollob K. J., Palmer E. An endogenous retrovirus mediating deletion of alpha beta T cells? Nature. 1991 Feb 7;349(6309):529–530. doi: 10.1038/349529a0. [DOI] [PubMed] [Google Scholar]
  84. Woodland D. L., Lund F. E., Happ M. P., Blackman M. A., Palmer E., Corley R. B. Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci. J Exp Med. 1991 Nov 1;174(5):1255–1258. doi: 10.1084/jem.174.5.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Woodland D. L., Smith H. P., Surman S., Le P., Wen R., Blackman M. A. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J Exp Med. 1993 Feb 1;177(2):433–442. doi: 10.1084/jem.177.2.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Yonaha F., Sumida T., Maeda T., Tomioka H., Koike T., Yoshida S. Restricted junctional usage of T cell receptor V beta 2 and V beta 13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjögren's syndrome. Arthritis Rheum. 1992 Nov;35(11):1362–1367. doi: 10.1002/art.1780351118. [DOI] [PubMed] [Google Scholar]
  87. von Knebel Doeberitz M., Bornkamm G. W., zur Hausen H. Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A. Med Microbiol Immunol. 1983;172(2):87–99. doi: 10.1007/BF02124509. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES